09:46 AM EST - Neovasc Inc. : Announced today that the Neovasc Reducer was featured in a special issue titled: "The Future of Medicine" of National Graphic Magazine, published in December 2019. An image of the Reducer was accompanied by a case study of a patient who was implanted with the Reducer. Neovasc's Medical Director, Prof. Shmuel Banai, MD, Director of the Division of Cardiology and the Head of Interventional Cardiology at the Tel Aviv Medical Center, Tel Aviv, Israel, is also prominently featured. Neovasc Inc.
shares T.NVCN are trading up $0.38 at $4.64.
